Ciriana Orabona is an associate professor at the Section of Pharmacology, Department of Medicine and Surgery, University of Perugia, Italy. She graduated in Drug Chemistry and Technology in 1997 from the University of Perugia, and earned a Ph.D. in Experimental Medicine, discussing a thesis on the IDO1 enzyme as a new tolerogenic mechanism in dendritic cells in 2003. She spent the first part (1998–2000) of her Ph.D. training at the Ludwig Institute for Cancer Research in Brussels, where she acquired great expertise in signal transduction analysis. She is also a member of the European Association for the Study of Diabetes (EFSD), the Italian Society of Neurosciences (SINS), and the Italian Society of Pharmacology (SIF). Her main research interests include immunopharmacology, immunotherapy, and tryptophan metabolism in the regulation of the immune response in autoimmune, neoplastic, and inflammatory chronic diseases.